"Fidji Simo announced that she will be taking medical leave for several weeks to navigate a neuroimmune condition, stating, 'I have done everything possible to avoid it, but sadly my body isn't cooperating.'"
"Simo expressed frustration about her timing away from the company, saying, 'The timing is maddening because we have such an exciting roadmap ahead that the team is executing on, and I hate to miss even a minute of it.'"
"OpenAI confirmed that they have a strong leadership team focused on key priorities, stating, 'We're well-positioned to keep advancing frontier research, growing our global user base of nearly 1 billion users, and powering enterprise use cases.'"
"Kate Rouch will step down from her role to focus on cancer recovery, with plans to return to a 'different, more narrowly scoped role when her health allows.'"
OpenAI is undergoing significant executive changes, with COO Brad Lightcap transitioning to lead special projects focused on complex deals and investments. Denise Dresser, the new Chief Revenue Officer, will temporarily assume some of Lightcap's responsibilities. CEO Fidji Simo announced her medical leave due to a neuroimmune condition, while CMO Kate Rouch is stepping down to focus on cancer recovery. Greg Brockman will manage product during Simo's absence, and OpenAI is searching for a new CMO.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]